← Leaderboards
Adolfo A. Ferrando
Columbia University Health Sciences
$15,202,284
Attributed
$19,172,892
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2007–21$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$19,172,892 · 10
By mechanism
R01$11,186,267 · 7
R35$4,705,442 · 1
UG1$2,711,464 · 1
P30$569,719 · 1
Top collaborators
- Riccardo Dalla-Favera5 shared
- Brent R Stockwell5 shared
- Ari M. Melnick3 shared
- Omar Abdel-Wahab2 shared
- Ross L Levine2 shared
- Raul Rabadan1 shared
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularProgramsMediatingMutationPathway InteractionsLeukemiaOncogenicHematologic NeoplasmsPathogenesisResponseChemotherapyBaseCell ProliferationCellsNotch1 GeneAdult Acute Lymphocytic LeukemiaChildhoodAccountingDisease ProgressionResistanceSignal TransductionGeneticInhibitor/AntagonistRelapse
Grant awards (47)
Molecular pathways and targeted therapies in human leukemia$960,000
R35 · FY2021 · CA · contact PI
ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)$892,711
UG1 · FY2021 · CA
The role of PHF6 in the control of hematopoietic stem cell aging.$500,000
R01 · FY2021 · AG · contact PI
Molecular characterization and targeting of NT5C2 mutations in acute lymphoblastic leukemia$383,548
R01 · FY2021 · CA · contact PI
Molecular pathways and targeted therapies in human leukemia$1,004,909
R35 · FY2020 · CA · contact PI
ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)$859,607
UG1 · FY2020 · CA
Molecular characterization and targeting of NT5C2 mutations in acute lymphoblastic leukemia$383,193
R01 · FY2020 · CA · contact PI
ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)$959,146
UG1 · FY2019 · CA
Molecular pathways and targeted therapies in human leukemia$931,200
R35 · FY2019 · CA · contact PI
Molecular characterization and targeting of NT5C2 mutations in acute lymphoblastic leukemia$371,168
R01 · FY2019 · CA · contact PI
Molecular pathways and targeted therapies in human leukemia$960,000
R35 · FY2018 · CA · contact PI
Molecular characterization and targeting of NT5C2 mutations in acute lymphoblastic leukemia$382,254
R01 · FY2018 · CA · contact PI
Molecular pathways and targeted therapies in human leukemia$849,333
R35 · FY2017 · CA · contact PI
Molecular characterization and targeting of NT5C2 mutations in acute lymphoblastic leukemia$381,673
R01 · FY2017 · CA · contact PI
The Role of NOTCH1 in the Pathogenesis of CLL.$358,315
R01 · FY2017 · CA
The role of ETV6 in T-cell acute lymphoblastic leukemia$332,000
R01 · FY2017 · CA · contact PI
The Role of NOTCH1 in the Pathogenesis of CLL.$358,315
R01 · FY2016 · CA
The role of ETV6 in T-cell acute lymphoblastic leukemia$332,000
R01 · FY2016 · CA · contact PI
The Role of NOTCH1 in the Pathogenesis of CLL.$358,315
R01 · FY2015 · CA
The role of PHF6 in T-cell acute lymphoblastic leukemia$332,000
R01 · FY2015 · CA · contact PI
The role of ETV6 in T-cell acute lymphoblastic leukemia$332,000
R01 · FY2015 · CA · contact PI
The Role of NOTCH1 in the Pathogenesis of CLL.$347,566
R01 · FY2014 · CA
The role of PHF6 in T-cell acute lymphoblastic leukemia$322,040
R01 · FY2014 · CA · contact PI
The role of ETV6 in T-cell acute lymphoblastic leukemia$322,040
R01 · FY2014 · CA · contact PI
The Role of NOTCH1 in the Pathogenesis of CLL.$358,315
R01 · FY2013 · CA
The role of ETV6 in T-cell acute lymphoblastic leukemia$332,000
R01 · FY2013 · CA · contact PI
The role of PHF6 in T-cell acute lymphoblastic leukemia$312,080
R01 · FY2013 · CA · contact PI
GENOMICS TECHNOLOGIES RESOURCE$136,392
P30 · FY2013 · CA · contact PI
The role of PHF6 in T-cell acute lymphoblastic leukemia$332,000
R01 · FY2012 · CA · contact PI
The role of AKT signaling in NOTCH1 induced leukemias$324,613
R01 · FY2012 · CA · contact PI
GENOMICS TECHNOLOGIES RESOURCE$85,007
P30 · FY2012 · CA · contact PI
The role of PHF6 in T-cell acute lymphoblastic leukemia$333,211
R01 · FY2011 · CA · contact PI
The role of AKT signaling in NOTCH1 induced leukemias$324,598
R01 · FY2011 · CA · contact PI
Mechanisms of T-Cell Leukemogenesis Induced by Notch1$296,723
R01 · FY2011 · CA · contact PI
GENOMICS TECHNOLOGIES RESOURCE$94,921
P30 · FY2011 · CA · contact PI
The role of AKT signaling in NOTCH1 induced leukemias$337,189
R01 · FY2010 · CA · contact PI
Mechanisms of T-Cell Leukemogenesis Induced by Notch1$305,900
R01 · FY2010 · CA · contact PI
GENOMICS TECHNOLOGIES RESOURCE$96,943
P30 · FY2010 · CA · contact PI
Mechanisms of T-cell leukemogenesis induced by NOTCH1$533,649
R01 · FY2009 · CA · contact PI
The role of AKT signaling in NOTCH1 induced leukemias$341,043
R01 · FY2009 · CA · contact PI
Mechanisms of T-Cell Leukemogenesis Induced by Notch1$305,900
R01 · FY2009 · CA · contact PI
GENOMICS TECHNOLOGIES RESOURCE$96,529
P30 · FY2009 · CA · contact PI
GENOMICS TECHNOLOGIES RESOURCE$1,177
P30 · FY2009 · CA · contact PI
The role of AKT signaling in NOTCH1 induced leukemias$340,819
R01 · FY2008 · CA · contact PI
Mechanisms of T-Cell Leukemogenesis Induced by Notch1$305,900
R01 · FY2008 · CA · contact PI
GENOMICS TECHNOLOGIES RESOURCE$58,750
P30 · FY2008 · CA · contact PI
Mechanisms of T-Cell Leukemogenesis Induced by Notch1$305,900
R01 · FY2007 · CA · contact PI